ORKA
Price
$15.23
Change
+$0.05 (+0.33%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
571.87M
SLXN
Price
$7.74
Change
+$0.48 (+6.61%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
5.66M
Interact to see
Advertisement

ORKA vs SLXN

Header iconORKA vs SLXN Comparison
Open Charts ORKA vs SLXNBanner chart's image
Oruka Therapeutics
Price$15.23
Change+$0.05 (+0.33%)
Volume$2.07K
Capitalization571.87M
Silexion Therapeutics
Price$7.74
Change+$0.48 (+6.61%)
Volume$300
Capitalization5.66M
ORKA vs SLXN Comparison Chart in %
Loading...
ORKA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORKA vs. SLXN commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORKA is a Buy and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ORKA: $15.18 vs. SLXN: $7.26)
Brand notoriety: ORKA and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORKA: 77% vs. SLXN: 19%
Market capitalization -- ORKA: $571.87M vs. SLXN: $5.66M
ORKA [@Biotechnology] is valued at $571.87M. SLXN’s [@Biotechnology] market capitalization is $5.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORKA’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • ORKA’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, ORKA is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORKA’s TA Score shows that 3 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • ORKA’s TA Score: 3 bullish, 5 bearish.
  • SLXN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than ORKA.

Price Growth

ORKA (@Biotechnology) experienced а +5.42% price change this week, while SLXN (@Biotechnology) price change was +6.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORKA($572M) has a higher market cap than SLXN($5.66M). ORKA YTD gains are higher at: -21.712 vs. SLXN (-75.920). ORKA has more cash in the bank: 328M vs. SLXN (3.47M). ORKA has less debt than SLXN: ORKA (2.33M) vs SLXN (3.7M).
ORKASLXNORKA / SLXN
Capitalization572M5.66M10,108%
EBITDAN/A-17.81M-
Gain YTD-21.712-75.92029%
P/E RatioN/AN/A-
RevenueN/A0-
Total Cash328M3.47M9,463%
Total Debt2.33M3.7M63%
FUNDAMENTALS RATINGS
ORKA: Fundamental Ratings
ORKA
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
14

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ORKASLXN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
35%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
22%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
28%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
27%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
53%
Declines
ODDS (%)
Bearish Trend 9 days ago
79%
Bearish Trend 8 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 4 days ago
38%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ORKA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSFRX24.670.19
+0.78%
Federated Hermes Clover Small Value R
SWANX24.99N/A
N/A
Schwab Core Equity
BROIX22.43N/A
N/A
BlackRock Advantage International Instl
JSJIX16.97N/A
N/A
JHancock Small Cap Dynamic Growth I
CAISX12.02-0.06
-0.50%
Calamos International Small Cap Gr A

ORKA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORKA has been loosely correlated with PCVX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORKA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORKA
1D Price
Change %
ORKA100%
+2.50%
PCVX - ORKA
44%
Loosely correlated
+0.99%
RLFTF - ORKA
31%
Poorly correlated
+4.18%
ENTX - ORKA
30%
Poorly correlated
-1.01%
CMMB - ORKA
28%
Poorly correlated
+2.35%
RLFTY - ORKA
24%
Poorly correlated
N/A
More

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
+0.83%
IMA - SLXN
63%
Loosely correlated
+0.07%
CELC - SLXN
50%
Loosely correlated
+1.01%
MRSN - SLXN
43%
Loosely correlated
-0.26%
CHRS - SLXN
26%
Poorly correlated
+0.88%
QSI - SLXN
25%
Poorly correlated
-0.85%
More